CN112472871B - 一种提高力学及抗凝血性能的生物瓣膜交联方法 - Google Patents
一种提高力学及抗凝血性能的生物瓣膜交联方法 Download PDFInfo
- Publication number
- CN112472871B CN112472871B CN202011421499.5A CN202011421499A CN112472871B CN 112472871 B CN112472871 B CN 112472871B CN 202011421499 A CN202011421499 A CN 202011421499A CN 112472871 B CN112472871 B CN 112472871B
- Authority
- CN
- China
- Prior art keywords
- biological
- valve
- crosslinking
- diphenol
- cross
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000004132 cross linking Methods 0.000 title claims abstract description 46
- 238000000034 method Methods 0.000 title claims abstract description 26
- 230000002429 anti-coagulating effect Effects 0.000 title description 3
- IBGBGRVKPALMCQ-UHFFFAOYSA-N 3,4-dihydroxybenzaldehyde Chemical compound OC1=CC=C(C=O)C=C1O IBGBGRVKPALMCQ-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000012620 biological material Substances 0.000 claims abstract description 33
- 239000000463 material Substances 0.000 claims abstract description 31
- XKZQKPRCPNGNFR-UHFFFAOYSA-N 2-(3-hydroxyphenyl)phenol Chemical group OC1=CC=CC(C=2C(=CC=CC=2)O)=C1 XKZQKPRCPNGNFR-UHFFFAOYSA-N 0.000 claims abstract description 21
- PCYGLFXKCBFGPC-UHFFFAOYSA-N 3,4-Dihydroxy hydroxymethyl benzene Natural products OCC1=CC=C(O)C(O)=C1 PCYGLFXKCBFGPC-UHFFFAOYSA-N 0.000 claims abstract description 18
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 claims abstract description 13
- 230000010100 anticoagulation Effects 0.000 claims abstract description 12
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 18
- 229910001870 ammonium persulfate Inorganic materials 0.000 claims description 11
- 230000001590 oxidative effect Effects 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 8
- 229910021641 deionized water Inorganic materials 0.000 claims description 8
- 210000003709 heart valve Anatomy 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 210000001765 aortic valve Anatomy 0.000 claims description 3
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 125000003172 aldehyde group Chemical group 0.000 claims description 2
- 125000003277 amino group Chemical group 0.000 claims description 2
- 235000010290 biphenyl Nutrition 0.000 claims description 2
- 239000004305 biphenyl Substances 0.000 claims description 2
- 238000006297 dehydration reaction Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 210000004115 mitral valve Anatomy 0.000 claims description 2
- 230000004048 modification Effects 0.000 claims description 2
- 238000012986 modification Methods 0.000 claims description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 claims description 2
- 210000003102 pulmonary valve Anatomy 0.000 claims description 2
- 238000001356 surgical procedure Methods 0.000 claims description 2
- 210000000591 tricuspid valve Anatomy 0.000 claims description 2
- 210000002073 venous valve Anatomy 0.000 claims description 2
- 239000003146 anticoagulant agent Substances 0.000 abstract description 3
- 230000000702 anti-platelet effect Effects 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 210000003516 pericardium Anatomy 0.000 description 8
- 208000007536 Thrombosis Diseases 0.000 description 7
- 238000012360 testing method Methods 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 238000004626 scanning electron microscopy Methods 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000002592 echocardiography Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 210000002418 meninge Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
- A61L27/3687—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/40—Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Veterinary Medicine (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Botany (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
Claims (9)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011421499.5A CN112472871B (zh) | 2020-12-08 | 2020-12-08 | 一种提高力学及抗凝血性能的生物瓣膜交联方法 |
PCT/CN2021/136200 WO2022121912A1 (zh) | 2020-12-08 | 2021-12-07 | 一种提高力学及抗凝血性能的生物瓣膜交联方法、生物瓣膜材料及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011421499.5A CN112472871B (zh) | 2020-12-08 | 2020-12-08 | 一种提高力学及抗凝血性能的生物瓣膜交联方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112472871A CN112472871A (zh) | 2021-03-12 |
CN112472871B true CN112472871B (zh) | 2022-05-24 |
Family
ID=74940499
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011421499.5A Active CN112472871B (zh) | 2020-12-08 | 2020-12-08 | 一种提高力学及抗凝血性能的生物瓣膜交联方法 |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN112472871B (zh) |
WO (1) | WO2022121912A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112472871B (zh) * | 2020-12-08 | 2022-05-24 | 吉林启明皓月生物科技有限公司 | 一种提高力学及抗凝血性能的生物瓣膜交联方法 |
CN114748693B (zh) * | 2021-11-17 | 2022-11-15 | 四川大学 | 一种共交联联合双键交联制备生物瓣膜材料的方法及生物瓣膜材料 |
CN113952513B (zh) * | 2021-11-29 | 2022-11-15 | 四川大学华西医院 | 一种抗衰败人工生物瓣膜及其制备方法和应用 |
CN117504003A (zh) * | 2022-08-04 | 2024-02-06 | 吉林启明皓月生物科技有限公司 | 生物膜材料加工方法、生物膜材料以及人工生物瓣膜 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020120333A1 (en) * | 2001-01-31 | 2002-08-29 | Keogh James R. | Method for coating medical device surfaces |
CN101224313B (zh) * | 2008-02-04 | 2012-02-15 | 中国科学院上海硅酸盐研究所 | 采用槲皮素交联制备人工生物心脏瓣膜材料的方法 |
PL3157467T3 (pl) * | 2014-06-17 | 2019-01-31 | Consiglio Nazionale Delle Ricerche | Sposób wytwarzania zastawki serca z materiału polimerowego i zastawka serca uzyskana tym sposobem |
CN108159482A (zh) * | 2018-01-02 | 2018-06-15 | 上海其胜生物制剂有限公司 | 一种具有温敏特性和高组织粘附力的可注射天然水凝胶体系及其制备方法 |
CN108498869B (zh) * | 2018-04-08 | 2020-12-25 | 中国医学科学院生物医学工程研究所 | 多酚类交联剂及其在制备抗钙化生物瓣膜中的应用 |
CN108721704B (zh) * | 2018-07-05 | 2020-03-10 | 四川大学 | 一种兼具抗钙化与抗增生双功能的长效缓释心血管涂层材料及其制备方法 |
CN109820624B (zh) * | 2018-09-29 | 2019-12-06 | 四川大学 | 一种采用光交联处理生物瓣膜的方法 |
CN109820625A (zh) * | 2018-09-30 | 2019-05-31 | 四川大学 | 一种交联的人工生物瓣膜处理方法 |
CN110201219A (zh) * | 2019-05-14 | 2019-09-06 | 浙江理工大学 | 一种可注射且快速凝胶化的复合水凝胶及其制备方法 |
CN110585486B (zh) * | 2019-08-28 | 2021-11-30 | 湖南光琇医院有限公司 | 羊膜复合材料及其制备方法和应用 |
CN111166938B (zh) * | 2020-02-17 | 2020-10-30 | 四川大学 | 一种非戊二醛可预装干燥生物瓣膜材料及制备方法和应用 |
CN111569152A (zh) * | 2020-05-28 | 2020-08-25 | 四川大学 | 一种兼具抗凝血和抗钙化性能的生物瓣膜及其制备方法 |
CN112472871B (zh) * | 2020-12-08 | 2022-05-24 | 吉林启明皓月生物科技有限公司 | 一种提高力学及抗凝血性能的生物瓣膜交联方法 |
CN112641998B (zh) * | 2020-12-22 | 2021-10-15 | 四川大学 | 一种长效超疏水抗凝生物瓣膜及其制备方法 |
-
2020
- 2020-12-08 CN CN202011421499.5A patent/CN112472871B/zh active Active
-
2021
- 2021-12-07 WO PCT/CN2021/136200 patent/WO2022121912A1/zh active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2022121912A1 (zh) | 2022-06-16 |
CN112472871A (zh) | 2021-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112472871B (zh) | 一种提高力学及抗凝血性能的生物瓣膜交联方法 | |
CN111569152A (zh) | 一种兼具抗凝血和抗钙化性能的生物瓣膜及其制备方法 | |
Mackay et al. | New polyurethane heart valve prosthesis: design, manufacture and evaluation | |
CN111420120A (zh) | 一种具有抗凝血和抗钙化功能的生物瓣膜及其制备方法 | |
US20230093191A1 (en) | Biological Material And Preparation Method Therefor | |
CN112220971B (zh) | 一种人工生物心脏瓣膜及其制备方法 | |
WO1996007373A1 (en) | Natural tissue valve prosthesis, and manufacturing method | |
CN110152065B (zh) | 一种仿生微纳叠层疏水生物瓣膜及其制备方法 | |
Jin et al. | Cross-linking methacrylated porcine pericardium by radical polymerization confers enhanced extracellular matrix stability, reduced calcification, and mitigated immune response to bioprosthetic heart valves | |
WO2013063842A1 (zh) | 一种边缘刚性化人工生物瓣膜的制备方法 | |
CN111701077B (zh) | 一种具有抗血栓抗钙化功能的瓣膜及其制备方法和应用 | |
US20230218803A1 (en) | Valve Material With Combined Anti-Clotting And Anti-Calcification Properties And Preparation Method Therefor | |
Singh et al. | Polymeric prosthetic heart valves: a review of current technologies and future directions | |
Cheng et al. | Double‐network hydrogel armored decellularized porcine pericardium as durable bioprosthetic heart valves | |
Yu et al. | A bioprosthetic heart valve cross-linked by a non-glutaraldehyde reagent with improved biocompatibility, endothelialization, anti-coagulation and anti-calcification properties | |
CN111494717A (zh) | 一种人工生物瓣膜及其制备方法 | |
CN107412871A (zh) | 一种基底膜成分表层的人工生物心脏/血管瓣膜及其制备方法 | |
CN112263715B (zh) | 一种抗凝血抗钙化的人工心脏瓣膜材料及其制备方法与应用 | |
CN112220970A (zh) | 一种抗凝血的人工心脏瓣膜材料及其制备方法与应用 | |
Liang et al. | Poly (2-methoxyethyl acrylate) coated bioprosthetic heart valves by copolymerization with enhanced anticoagulant, anti-inflammatory, and anti-calcification properties | |
Vasudev et al. | Polyethylene glycol-grafted bovine pericardium: a novel hybrid tissue resistant to calcification | |
CN112773936A (zh) | 一种改性心包膜及其制备方法、人工心脏瓣膜假体 | |
Tong et al. | Recent Advances in the Modification and Improvement of Bioprosthetic Heart Valves | |
EP3876869A1 (en) | The system of an element used for the creation of heart valve, the method of manufacturing of modified bacterial cellulose (bc), the set and the element used in cardio surgery | |
Pierce | Polymers in biomedical devices: Materials for artificial heart and circulatory assist devices |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20220308 Address after: 130013 No. 11111, Haoyue Road, Luyuan District, Changchun City, Jilin Province (Room 101, office building of Jilin Changchun Haoyue Halal Meat Industry Co., Ltd.) Applicant after: Jilin Qiming Haoyue Biotechnology Co.,Ltd. Address before: 610041 No. three, South Renmin Road, Sichuan, Chengdu province 17 Applicant before: SICHUAN University |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PP01 | Preservation of patent right |
Effective date of registration: 20240319 Granted publication date: 20220524 |
|
PP01 | Preservation of patent right |